Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.
The FDA placed a clinical hold on two Atara assets, following an inspection at a third-party site that also led to a CRL for ...
GlobalData on MSN13h
FDA lifts hold on Opella’s trial to support switch of Cialis to OTC drugThe US Food and Drug Administration (FDA) has removed the clinical hold on a trial of Cialis (tadalafil) by Sanofi's consumer ...
Many of Washington’s biggest lobbying firms notched a strong close to the Biden administration in defiance of the usual ...
H.C. Wainwright analyst Robert Burns has reiterated their neutral stance on ATRA stock, giving a Hold rating yesterday.Invest with Confidence: ...
Consisting of five separate booklets, the World Drug Report 2022 provides an in-depth analysis of global drug markets and examines the nexus between drugs and the environment within the bigger picture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback